|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
1.95(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$35.77 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
32,136 |
465,065 |
655,744 |
1,062,982 |
Total Sell Value |
$1,503,716 |
$26,033,932 |
$35,438,128 |
$50,015,597 |
Total People Sold |
3 |
7 |
9 |
11 |
Total Sell Transactions |
5 |
17 |
34 |
71 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2022-06-04 |
4 |
D |
$37.77 |
$9,971 |
D/D |
(264) |
61,735 |
|
- |
|
Petersen Floyd F. |
Director |
|
2022-06-01 |
4 |
AS |
$36.79 |
$18,499 |
D/D |
(500) |
85,945 |
|
-25% |
|
Lee Howard |
Director |
|
2022-05-23 |
4 |
S |
$34.93 |
$349,323 |
D/D |
(10,000) |
138,776 |
|
18% |
|
Lee Howard |
Director |
|
2022-05-23 |
4 |
OE |
$17.11 |
$171,100 |
D/D |
10,000 |
148,776 |
|
- |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-05-20 |
4 |
AS |
$34.21 |
$364,365 |
D/D |
(10,650) |
2,104,143 |
|
-17% |
|
Peters William J |
CFO, EVP & Treasurer |
|
2022-05-19 |
4 |
D |
$33.70 |
$12,739 |
D/D |
(378) |
104,609 |
|
- |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-05-19 |
4 |
AS |
$33.76 |
$1,408,761 |
D/D |
(41,730) |
2,114,793 |
|
-14% |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-05-18 |
4 |
AS |
$33.97 |
$2,289,101 |
D/D |
(67,046) |
2,156,523 |
|
-14% |
|
Petersen Floyd F. |
Director |
|
2022-05-18 |
4 |
S |
$35.05 |
$347,826 |
D/D |
(9,924) |
86,445 |
|
14% |
|
Petersen Floyd F. |
Director |
|
2022-05-18 |
4 |
OE |
$17.11 |
$347,179 |
D/D |
20,291 |
96,369 |
|
- |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-05-17 |
4 |
AS |
$35.74 |
$1,801,440 |
D/D |
(50,376) |
2,223,569 |
|
-21% |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-05-16 |
4 |
AS |
$35.58 |
$2,433,457 |
D/D |
(68,069) |
2,273,945 |
|
-20% |
|
Zasloff Michael A |
Director |
|
2022-05-16 |
4 |
S |
$35.61 |
$366,500 |
D/D |
(10,291) |
47,206 |
|
20% |
|
Zasloff Michael A |
Director |
|
2022-05-16 |
4 |
OE |
$17.11 |
$176,079 |
D/D |
10,291 |
57,497 |
|
- |
|
Petersen Floyd F. |
Director |
|
2022-05-02 |
4 |
AS |
$35.15 |
$10,378 |
D/D |
(295) |
76,078 |
|
-18% |
|
Petersen Floyd F. |
Director |
|
2022-04-01 |
4 |
AS |
$36.59 |
$18,345 |
D/D |
(500) |
76,373 |
|
-16% |
|
Zhou Rong |
EVP, Production Center |
|
2022-03-17 |
4 |
D |
$34.18 |
$83,638 |
D/D |
(2,447) |
77,583 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2022-03-17 |
4 |
D |
$34.18 |
$142,257 |
D/D |
(4,162) |
104,987 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2022-03-17 |
4 |
D |
$34.18 |
$57,183 |
D/D |
(1,673) |
60,740 |
|
- |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-03-17 |
4 |
D |
$34.18 |
$241,037 |
I/I |
(7,052) |
1,498,519 |
|
- |
|
Luo Mary Z. |
CEO & Chief Scientific Officer |
|
2022-03-17 |
4 |
D |
$34.18 |
$538,950 |
D/D |
(15,768) |
2,342,014 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2022-03-16 |
4 |
D |
$34.22 |
$78,124 |
D/D |
(2,283) |
80,030 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2022-03-16 |
4 |
D |
$34.22 |
$170,929 |
D/D |
(4,995) |
109,149 |
|
- |
|
Peters William J |
CFO, EVP & Treasurer |
|
2022-03-16 |
4 |
S |
$33.93 |
$1,724,427 |
D/D |
(50,777) |
114,144 |
|
-8% |
|
Peters William J |
CFO, EVP & Treasurer |
|
2022-03-16 |
4 |
OE |
$14.40 |
$731,189 |
D/D |
50,777 |
164,921 |
|
- |
|
954 Records found
|
|
Page 7 of 39 |
|
|